famotidine has been researched along with Musculoskeletal Pain in 1 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Musculoskeletal Pain: Discomfort stemming from muscles, LIGAMENTS, tendons, and bones.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Type of cancer, treatment, age, and BMI were not significant predictors of bone pain." | 1.46 | Prevention of granulocyte-colony stimulating factor (G-CSF) induced bone pain using double histamine blockade. ( Abrams, M; Gavioli, E, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gavioli, E | 1 |
| Abrams, M | 1 |
1 other study available for famotidine and Musculoskeletal Pain
| Article | Year |
|---|---|
Prevention of granulocyte-colony stimulating factor (G-CSF) induced bone pain using double histamine blockade.
Topics: Aged; Antineoplastic Agents; Bone Diseases; Cohort Studies; Famotidine; Febrile Neutropenia; Female; | 2017 |